AV Aris Vangelis
Clinical Research Specialist
Background
Aris Vangelis has spent over two decades studying how natural compounds interact with the human stress response system. His early work involved deep-dive analyses of cortisol dysregulation and its downstream effects on hippocampal neuroplasticity -- research that laid the foundation for much of what Neurum understands about chronic stress and cognitive decline.
Throughout his career in clinical research, Vangelis has worked alongside specialized teams focusing on anxiety disorders, burnout syndrome, and age-related cognitive impairment. It was during this period that he became deeply interested in adaptogenic herbs -- natural compounds like Ashwagandha, Rhodiola, and Holy Basil that modulate the HPA axis without the side-effect profiles of many standard interventions.
Research Philosophy
"I believe the supplement industry has a fundamental honesty problem. There are compounds with genuinely remarkable clinical evidence -- and then there are hundreds of products riding on misleading claims and cherry-picked data. My role at Neurum is to separate what works from what is marketing fiction."
Vangelis approaches every ingredient with a simple framework: What does the published evidence actually show? In what populations? At what doses? And most importantly -- what are the limitations and risks that most supplement companies conveniently leave out?
Contribution to Neurum
At Neurum, Vangelis leads the ingredient research pipeline, focusing on adaptogens, anxiolytic compounds, and neuroprotective agents. He is responsible for the deep-dive ingredient profiles covering mechanisms of action, clinical trial analysis, dosing protocols, and safety considerations.
- Ashwagandha (KSM-66 vs Sensoril analysis)
- Rhodiola Rosea and stress resilience
- L-Theanine and the caffeine-theanine synergy
- Bacopa Monnieri and long-term memory consolidation
- Magnesium forms and brain-specific bioavailability
- GABA, Kava, and natural anxiolytics
Research Methodology
Evidence Hierarchy
Systematic reviews and meta-analyses first, then RCTs, then cohort studies. Animal and in-vitro data are noted but clearly distinguished from human evidence.
Dose Verification
Every dosing recommendation is cross-referenced against the doses actually used in clinical trials -- not extrapolated from animal studies or theoretical calculations.
Conflict of Interest Check
Studies funded by supplement manufacturers are flagged and their findings are weighted accordingly. Independent research is always prioritized.
Consumer Safety First
Drug interactions, contraindications, and quality red flags are never omitted. If a compound has risks, readers will know about them.